RI
Gedeon Richter
RICHT.BU·BUDBudapest HUFounded 190112,000 employees
Mid CappharmaPublicCNSWomen's Health
Platform: CNS Women's
Market Cap
$5B
All Drugs
3
Clinical Trials
5
Failed / Terminated
2
FDA Approved
0
Stock Price & Catalysts (RICHT.BU)
Loading RICHT.BU stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RIC-4332 | RIC-4332 | Phase 3 | 2 | CD123 | CholangiocarcinomaBCC | ||
| Lisozasiran | RIC-6226 | NDA/BLA | 2 | VEGF | GISTSCD | ||
| RIC-2161 | RIC-2161 | Phase 2/3 | 1 | ALK | Wet AMDT2D |
SEC Filings & Financial Documents
SEC filings are not available for BUD-listed companies.
Gedeon Richter trades on BUD (HU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (6)